A prospective investigation of bile acids, hepatobiliary cancer and liver disease mortality in the alpha-tocopherol beta-carotene (atbc) prevention study
Ended Awarded Last action
- Contract number
- HHSN26100005
- Awardee
-
Metabolon, Inc. UEI SBY5A7EK9PU3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $38,400
Award facts
- Opportunity
-
- N02CP7100272 Solicitation number
- Metabolomic Profiling for Molecular Epidemiology Studies Award Notice · Posted Oct 31, 2016
- Contract value 100% obligated
- $38,400.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27713, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN26100005?
HHSN26100005 was awarded to Metabolon, Inc. by National Cancer Institute (National Institutes of Health) on April 2, 2018.
How much is contract HHSN26100005 worth?
The government has obligated $38,400 on HHSN26100005.
Is contract HHSN26100005 an order under another contract?
Yes. HHSN26100005 is a delivery order under HHSN261201700009I, an indefinite delivery contract.
Was contract HHSN26100005 competed?
The extent of competition for HHSN26100005 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award